Insulin Resistance and Atherosclerosis: The “Missing Link”
|
|
New research will highlight the “missing link” between the insulin resistance (metabolic) syndrome and cardiovascular disease at the American Association of Clinical Endocrinologists (AACE) 17th Annual Meeting & Clinical Congress, on Thursday, May 15, 2008, at the Walt Disney World Dolphin Resort in Orlando.
“Insulin resistant patients face a constellation of cardiovascular risk factors without diabetes ever being present,” AACE Member and the session’s speaker Ralph A. DeFronzo, MD said. “These must be seriously considered during treatment.”
During his session, Dr. DeFronzo will discuss the need to treat insulin resistance syndrome “early and aggressively.” Among a variety of approaches, he will consider how oral anti-diabetic medication may be helpful in the treatment of insulin resistant patients, therefore reducing the risk of cardiovascular events.
At the 2008 AACE Annual Meeting, the correlation between cardiovascular events and diabetes will be taking center stage. A special symposium titled “Clinical Trials Targeting Glycemia: What Do We Expect to Learn?” will consider the impact of glucose control through studies including ACCORD, ADVANCE, VADT, and others. Other sessions of interest include “Diabetes: A Cardiac Condition?” and “Hypoglycemia: The Limiting Factor in the Glycemic Management of Diabetes.”
Source: American Association of Clinical Endocrinologists (AACE)
Print Version
Tell-a-Friend comments powered by Disqus
